Related Experiment Video
Updated: Sep 3, 2026

Procedure and Key Optimization Strategies for an Automated Capillary Electrophoretic-based Immunoassay Method
Published on: September 10, 2017
Analysis of human p53 proteins and mRNA levels in normal and transformed cells
Abstract:
p53 mRNA and proteins were examined in a variety of human transformed cells and in normal human foreskin fibroblast cells. Both the steady-state and translatable levels of p53 mRNA were the same in normal and transformed human cells. In vitro synthesized p53, programmed by mRNA from normal and transformed human cells, revealed that there was heterogeneity in the primary structure of p53 from these cells. Pulse labeling of cells and immunoprecipitation analysis with a panel of human reactive anti-p53 antibodies demonstrated that the types of p53 synthesized in vitro corresponded to the types made in vivo from SV80 and COLO 320 cells. No p53 was detectable by similar pulse-labeling analysis of HeLa and normal foreskin fibroblast cells. Since it was necessary to use anti-p53 sera from cancer patients to carry out much of the immunoprecipitation analysis in this study we therefore further characterised these sera to determine if they reacted with one or more than one epitope. p53-beta-galactosidase fusion proteins were synthesized in Escherichia coli and used to analyse the anti-p53 antibodies produced by cancer patients. We demonstrate that the antisera contain antibodies directed against epitopes in both the N-terminal and C-terminal regions of the p53 molecule.
Insights
p53 mRNA levels are similar in normal and transformed human cells, but the synthesized p53 protein shows structural variations. Cancer patient antibodies recognize multiple p53 protein epitopes.
Area of Science:
- Molecular Biology
- Cancer Research
- Immunology
Background:
- The p53 protein is a critical tumor suppressor involved in cell cycle regulation and apoptosis.
- Alterations in p53 are common in human cancers, making it a key target for research.
- Understanding p53 expression and structure in both normal and cancerous cells is crucial for cancer diagnostics and therapeutics.
Purpose of the Study:
- To investigate the levels and structure of p53 mRNA and protein in various human transformed cell lines and normal fibroblasts.
- To characterize the epitopes recognized by anti-p53 antibodies from cancer patients.
Main Methods:
- Analysis of p53 mRNA and protein steady-state and translatable levels.
- In vitro protein synthesis programmed by cell mRNA.
- Pulse labeling and immunoprecipitation assays using anti-p53 antibodies.
- Synthesis of p53-beta-galactosidase fusion proteins for antibody characterization.
Main Results:
- Steady-state and translatable p53 mRNA levels were comparable in normal and transformed human cells.
- Synthesized p53 protein exhibited structural heterogeneity across different cell types.
- Immunoprecipitation confirmed that in vitro synthesized p53 matched in vivo synthesized p53 in SV80 and COLO 320 cells.
- p53 protein was not detectable in HeLa and normal foreskin fibroblast cells via pulse-labeling.
- Antibodies from cancer patient sera recognized epitopes in both N-terminal and C-terminal regions of the p53 molecule.
Conclusions:
- p53 protein structure, not mRNA levels, varies between normal and transformed human cells.
- Cancer patient-derived anti-p53 antibodies are polyclonal, targeting diverse epitopes on the p53 protein.
Related Concept Videos
Negative Regulator Molecules
DNA Damage can Stall the Cell Cycle
Abnormal Proliferation
DNA Damage Can Stall the Cell Cycle

